1. Home
  2. BOW vs MDXG Comparison

BOW vs MDXG Comparison

Compare BOW & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOW
  • MDXG
  • Stock Information
  • Founded
  • BOW 2020
  • MDXG 2006
  • Country
  • BOW United States
  • MDXG United States
  • Employees
  • BOW N/A
  • MDXG N/A
  • Industry
  • BOW Property-Casualty Insurers
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOW Finance
  • MDXG Health Care
  • Exchange
  • BOW Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • BOW 1.1B
  • MDXG 1.0B
  • IPO Year
  • BOW 2024
  • MDXG N/A
  • Fundamental
  • Price
  • BOW $25.80
  • MDXG $7.27
  • Analyst Decision
  • BOW Buy
  • MDXG Buy
  • Analyst Count
  • BOW 6
  • MDXG 1
  • Target Price
  • BOW $36.00
  • MDXG $12.00
  • AVG Volume (30 Days)
  • BOW 357.7K
  • MDXG 650.1K
  • Earning Date
  • BOW 11-04-2025
  • MDXG 10-29-2025
  • Dividend Yield
  • BOW N/A
  • MDXG N/A
  • EPS Growth
  • BOW 41.97
  • MDXG N/A
  • EPS
  • BOW 1.47
  • MDXG 0.21
  • Revenue
  • BOW $492,071,000.00
  • MDXG $363,774,000.00
  • Revenue This Year
  • BOW $19.49
  • MDXG $12.68
  • Revenue Next Year
  • BOW $21.79
  • MDXG $8.18
  • P/E Ratio
  • BOW $17.57
  • MDXG $34.82
  • Revenue Growth
  • BOW 41.21
  • MDXG 6.85
  • 52 Week Low
  • BOW $23.70
  • MDXG $5.47
  • 52 Week High
  • BOW $42.29
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • BOW 37.76
  • MDXG 56.76
  • Support Level
  • BOW $23.70
  • MDXG $6.62
  • Resistance Level
  • BOW $27.22
  • MDXG $7.04
  • Average True Range (ATR)
  • BOW 1.00
  • MDXG 0.23
  • MACD
  • BOW -0.08
  • MDXG 0.02
  • Stochastic Oscillator
  • BOW 41.05
  • MDXG 86.52

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: